Over half a million Americans receive radiation therapy as part of their cancer treatment each year. Within several years of their treatment, many of these patients will present with clinically-significant disorders, such as cardiomyopathy, pulmonary fibrosis, and cognitive decline. These injuries are classified as “normal tissue injury” due to their resulting from radiation exposure to the healthy tissues surrounding the targeted cancer tissue. Acute radiation damage to the microvascular endothelium (termed “radiation microvasculopathy”) is thought to eventually lead to a loss of capillaries, tissue ischemia, and, consequently, a loss of normal tissue function. Portions of this proposed sequence have been observed in vivo in preclinical models like rabbits and miniature pigs; however, to date, clinical data have been limited to descriptive studies of histopathology specimens or indirect indicators of poor perfusion or ischemia. While early perfusion defects and late loss of capillaries have been observed clinically using methods like laser Doppler and single photon emission computed tomography (SPECT), the use of radiotracers and radiographic imaging have made serial measurements within a single individual over time impractical. Furthermore, noninvasive methods capable of visualizing the microvessels with high enough resolution to simultaneously assess changes in both structure and function are currently missing. To effectively understand normal tissue injury development, especially the role of radiation microvasculopathy, new imaging modalities capable of assessing microvascular structure and function are needed. The purpose of this thesis work was to obtain an in-depth characterization of radiation microvasculopathy and its related pathologies in patients treated with radiotherapy for uveal melanoma, the most common primary intraocular cancer in adults. A cross-sectional cohort of 25 patients was assessed to test the hypothesis that radiation damage to the microvasculature precedes a loss of capillaries, neural tissue, and visual function in a dose- and time-dependent manner. Evidence for damage to the microvascular endothelium was identified by detecting vessel leakage and fluid accumulation in the retinal layers within the first 2 years from radiotherapy. During this same time period, decreases in blood flow compared to the contralateral, nonirradiated eye were observed. Importantly, these decreases in flow were observed before a loss of capillaries was detected. These early changes in blood flow and retinal layer thickness were followed by a loss of capillaries, thinning of the retinal tissue, and loss of visual function, indicative of ischemia and loss of normal tissue function. To enable studies of radiation microvasculopathy in mice, complementary methods for detecting changes in retinal blood flow were established in a C57/Bl6J mouse model, in both normal control mice and in mice with angiotensin-II-induced hypertension. Additionally, methods for measuring blood flow in mice exposed to a light flicker stimulus, used to assess vasodilation during neurovascular coupling, were established to enable the development of a preclinical model of radiation microvasculopathy in mice. Together, these data suggest hemodynamic changes can be detected before a loss of capillaries and normal tissue function, and indicate a need for a longitudinal study to confirm this sequence of normal tissue injury development.